AzTrials
AzTrials

FathersPERAM-QUALNCT02201433

Study on the Treatment of Children and Their Families in Services Related to Early Childhood

An observational study of Fathers and Premature Birth, run by University Hospital, Brest at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Breastfeeding is recommended for preterm infants. Development of breastfeeding is an important issue, requiring the involvement of medical and paramedical staff in neonatal units. There are few data concerning the fathers of preterm infants. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Fathers, Premature Birth
How many people
74 participants
Where
2 sitesFrance
Study dates
Jul 2014to Jan 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Part 1: caregivers and members of associations of preterm parents Part 2: fathers of preterm newborns, hospitalized in a neonatal intensive care unit Part 3: fathers who have experienced premature and caregivers of NICU who not participating in the first part

Who may be able to join

  • Member of Association of Parents of premature children major (born before 37 weeks)
  • Medical staff (doctors, nurses, pediatric nurses, social worker, ...) working in the NICU of the study.
  • Signing of free and informed consent
  • PART 2
  • major fathers of child born before 37 weeks who survived to the early neonatal period (7days),
  • French mother tongue,
Show all 17Show fewer
  • Residing in the geographical area of Brest
  • Signing of free and informed consent
  • Inclusion between Day 7 and Day 30 after the birth of their child
  • PART 3
  • fathers who have experienced child born premature
  • caregivers of NICU
  • PART 1, 2 and 3 exclusion criteria:
  • Person whose refuse to participate
  • Persons unable to consent
  • Persons whose monitoring is impossible
  • minor

Who cannot join

None listed.

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • CHRU de Brest

    Brest, 29200

  • CH du Mans

    Le Mans

Other trials in France

About this study

Official title: Study on the Treatment of Children and Their Families in Services Related to Early Childhood Morvan Hospital Qualitative Study

Breastfeeding is recommended for preterm infants. Development of breastfeeding is an important issue, requiring the involvement of medical and paramedical staff in neonatal units. There are few data concerning the fathers of preterm infants. However, the role of the father is identified in the literature as a key factor in the initiation and continuation of breastfeeding. In our neonatal unit care, reasons for breastfeeding high rates are not identified but may be related to the father being in close and constant contact with the medical and paramedical staff. In fact, fathers are often first in contact with caregivers. They can be invested in the implementation of nursing care, skin to skin, as well as being asked to support the development of their child in the service and at home.

The aims of this study are to:

  • Analyze the beliefs, social representations and the experience of the fathers of premature infants hospitalized in intensive care unit concerning breastfeeding.
  • Analyze the factors facilitating and inhibiting the initiation and continuation of breastfeeding.
  • Consider strategies of care and support that can be used for the families of premature infants and of children born at term.
  • Explore the expectations of medical staff with regards to the management of children and families, their practices, identify the role attributed to the father.
  • Initiate and facilitate reflexivity of medical and paramedical staff about their respective practices
Read the detailed description

The study will be conducted in three phases according to the methodology of qualitative research:

  • The first for the preparation of interview guides and observation grids through the inclusion of 20 participants: caregivers and members of associations of preterm parents,
  • The second part: maintenance by the inclusion of 40 fathers of children born preterm before 37 weeks and their partner if she wants.
  • The third part will, as in any qualitative analysis, data validation with the inclusion of 20 participants: fathers who experienced this situation in the context of care and caregivers close to neonatal intensive unit care (NICU) are participants in the first phase. interview methods:
  • 1 exploratory interview two hours on average with each part 1 and part 3 participants.
  • 3-5 interviews per part 2 participant. Interviews are conduct with guideline constructed during the first part of the study. Interview will be conducted by a nurse and /or a psychologist

Data analysis:

Full transcript of the interviews. Partial treatment during the study to enrich the interview guide until data saturation. All data will be treated differently: Software-aided thematic treatment (NVivo) and textual processing with cross medical data and socio-demographic variables (Alceste).

Data Validation :

Part 3 of the study external validation. Literature validation

Keywords
breastfeeding, fathers, preterm newborns, partner influence
Medical subject headings
Premature Birth, Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02201433
Study groupRoleWhat they receive
medical staff and member of an associationmembers of medical staff and member of an association of parents of premature infants. This cohort is necessary to build protocol interview for part 2 of the study
fathersfathers of preterm newborns
fathers or médical staffThis cohort is build for data validation. We will include fathers who have experienced this situation. Caregivers of NICU who are not participating in the first part

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Interviews

    PERAM QUAL is a qualitative study, in accordance with the methodology of qualitative study, it is not possible to establish a quantitative criterion of judgment.

    Full transcript of the interviews should permit the identification of factors that promote breastfeeding.

    Measured: Day 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2014 (estimated)
  2. Study startJul 2014
  3. Primary completionJan 2019
  4. Study completionJan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02201433
Sponsor's protocol ID
PERAM-QUAL
Acronym
PERAM-QUAL
Status last verified
May 2019
First submitted
9 Jul 2014
Last updated
29 May 2019
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Fathers and Premature Birth, run by University Hospital, Brest at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Interviews (time frame: Day 7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in